Etomidate 2 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Injection/Emulsion
Available Strengths: 2 mg/mL
Reference Brands: Amidate(US); Etomidate-Lipuro(EU)
Category: Critical Care
Etomidate is a fast-acting IV anesthetic used for induction and emergency intubation, available in 2 mg/mL strength. Leading brands include Amidate, Etomidate-Lipuro, and Hameln. A key ICU and OR medication, Etomidate is widely sourced via pharma B2B platforms for hospitals, emergency departments, and critical care units.
Product Description:
Etomidate is a rapid-onset intravenous anesthetic agent used primarily for the induction of general anesthesia and rapid sequence intubation (RSI), particularly in hemodynamically unstable patients. It is available as a 2 mg/mL solution in 10 mL and 20 mL vials, ampoules, or pre-filled syringes. In the US, Etomidate is marketed under the brand name Amidate by Pfizer, along with generics from Baxter, Hikma, and others. In the EU, Etomidate-Lipuro by B. Braun and Hameln brands are widely distributed. Etomidate is a critical care medication supplied through pharma B2B platforms to hospitals, emergency units, and surgical centers worldwide.
Etomidate — third party manufacturing & bulk supply
Etomidate 2 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Etomidate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Etomidate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Etomidate injection is used for the induction of general anesthesia and for short surgical or diagnostic procedures. It is commonly administered intravenously to induce rapid unconsciousness, especially in emergency settings where cardiovascular stability is important.
Etomidate injection is made from etomidate, a short-acting intravenous anesthetic agent. It works by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system, producing hypnosis with minimal effects on heart rate and blood pressure.
The most well-known trade name is Amidate.
Amidate was originally developed and marketed by Janssen Pharmaceuticals. Currently, etomidate injection is manufactured and distributed by various pharmaceutical companies worldwide depending on regional approvals.
The generic name is etomidate.
The brand name is Amidate.
Etomidate injection is manufactured in GMP-certified pharmaceutical facilities in the United States, Europe, India, and other regulated markets depending on the marketing authorization holder and supplier. Specific manufacturing locations vary by brand and batch.
Related Products
Ringer's Lactate
Strength:
100 mL, 250 mL, 500 mL, 1000ml
Form: Infusion
Reference Brands: Generic formulations marketed under different names
View Details
Rolapitant Hydrochlorid
Strength:
90 mg
Form: Tablets
Reference Brands: Varubi(USA/LATAM), Varuby(EU)
View Details
Conivaptan Hydrochloride
Strength:
20 mg/100 mL
Form: Infusion
Reference Brands: Vaprisol (USA)
View Details
Fitusiran
Strength:
50 mg/0.5 ml, 20 mg/0.2ml
Form: injection (prefilled syringe)
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
